Rothschild & Co Redburn | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

12,330 results for “Rothschild & Co Redburn”

Trials

View all 3003 →

Predicitve Value of Copeptin In CO-intoxicated Patients - A Prospective Cohort Study

120 participants · First posted Jan 18, 2022

Not yet recruiting

Co-Active Therapeutic Theatre (Co-ATT) for Dual-Diagnosis Patients

10 participants · First posted Jan 3, 2024

A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid Tumors

76 participants · First posted Sep 28, 2015

Drugs

View all 1005 →

CO-1bi

Cyanocobalamin Co-57

C₆₃H₈₉CoN₁₄O₁₄P

CO-1025

Organizations

View all 1535 →

Fondation A de Rothschild

France

Fondation Ophtalmologique Adolphe de Rothschild

France

Moelis & Co

News

View all 6787 →

AbbVie Surges on FDA Approval of Decnupaz for Rare Blood Cancer and European Nod for Migraine Therapy

KEYNOTE-057 Trial Explores Vibostolimab and Favezelimab Combinations with Pembrolizumab in BCG-Unresponsive NMIBC

PannTheraPi Receives ANSM Approval to Advance First-in-Class Panx1-Targeting Therapy PTI5803 into Phase 2a in Focal Cortical Dysplasia

Page 1 of 1233